Am. J. Respir. Cell Mol. Biol., Volume 18, Number 6, June, 1998 750-758

Lef1 Transcription Factor Expression Defines Airway Progenitor Cell Targets for In Utero Gene Therapy of Submucosal Gland in Cystic Fibrosis

Dongsheng Duan, Anil Sehgal, Jie Yao, and John F. Engelhardt

Department of Anatomy and Cell Biology, University of Iowa, Iowa City, Iowa

Cystic fibrosis (CF) has emerged as a paradigm disorder for assessing the utility of gene therapy in the treatment of genetic diseases. It is hypothesized that submucosal glands may play an important role in the pathophysiology of CF lung disease. However, this region poses several significant obstacles for gene therapy due to its inaccessibility from the lumen of adult proximal airways. In utero gene therapy to correct submucosal gland dysfunction in CF provides an attractive alternative strategy to target gland progenitor cells prior to gland formation and morphogenesis. Such approaches will require the use of integrating vectors capable of transducing expanding stem-cell/progenitor-cell populations in the lung. We described a newborn-ferret model of the proximal airway which was used to evaluate the phenotypic characteristics of submucosal gland progenitors and to test gene therapy strategies for targeting these cell types. To this end, we have isolated the ferret cDNA to the lymphoid enhancing factor 1 (Lef1) and have demonstrated that its mRNA expression specifically defines a subset of surface airway epithelial progenitor cells involved in the formation of primordial submucosal gland buds and subsequent gland morphogenesis. Such findings suggest that the transcriptional switch regulating activation of Lef1 expression defines the phenotype of early submucosal gland progenitor cells. In an effort to prove the principle of gene targeting to this progenitor-cell population, we evaluated the efficiency of recombinant retroviral vectors to target submucosal glands in a xenograft model system. Findings from these studies demonstrated successful gene targeting to progenitor cells of submucosal gland buds which was stable throughout subsequent gland development. In summary, these studies have provided evidence for the existence of phenotypically distinct submucosal gland progenitor cells which represent appropriate targets for gene therapy of submucosal glands in CF.

This article has been cited by other articles:

				M. Amen, X. Liu, U. Vadlamudi, G. Elizondo, E. Diamond, J. F. Engelhardt, and B. A. Amendt PITX2 and {beta}-Catenin Interactions Regulate Lef-1 Isoform Expression Mol. Cell. Biol., November 1, 2007; 27(21): 7560 - 7573. [Abstract] [Full Text] [PDF]

				Y. Maeda, V. Dave, and J. A. Whitsett Transcriptional Control of Lung Morphogenesis Physiol Rev, January 1, 2007; 87(1): 219 - 244. [Abstract] [Full Text] [PDF]

				R. R. Driskell, X. Liu, M. Luo, M. Filali, W. Zhou, D. Abbott, N. Cheng, C. Moothart, C. D. Sigmund, and J. F. Engelhardt Wnt-responsive element controls Lef-1 promoter expression during submucosal gland morphogenesis Am J Physiol Lung Cell Mol Physiol, October 1, 2004; 287(4): L752 - L763. [Abstract] [Full Text] [PDF]

				Z. Li, M. Rezaei Sabet, Q. Zhou, X. Liu, W. Ding, Y. Zhang, J.-P. Renard, and J. F. Engelhardt Developmental Capacity of Ferret Embryos by Nuclear Transfer Using G0/G1-Phase Fetal Fibroblasts Biol Reprod, June 1, 2003; 68(6): 2297 - 2303. [Abstract] [Full Text] [PDF]

				Z. Li, Q. Jiang, M. Rezaei Sabet, Y. Zhang, T. C. Ritchie, and J. F. Engelhardt Conditions for In Vitro Maturation and Artificial Activation of Ferret Oocytes Biol Reprod, May 1, 2002; 66(5): 1380 - 1386. [Abstract] [Full Text]

				J. F. Engelhardt Stem Cell Niches in the Mouse Airway Am. J. Respir. Cell Mol. Biol., June 1, 2001; 24(6): 649 - 652. [Full Text] [PDF]

				D Duan, Y Yue, W Zhou, B Labed, T. Ritchie, R Grosschedl, and J. Engelhardt Submucosal gland development in the airway is controlled by lymphoid enhancer binding factor 1 (LEF1) Development, January 10, 1999; 126(20): 4441 - 4453. [Abstract] [PDF]